CYP2A6 antibody

Synonyms:Coumarin 7 hydroxylase antibody, CPA6 antibody, CYP2A antibody, CYP2A3 antibody, CYP2A6 antibody, CYPIIA6 antibody, Cytochrome P450 2A6 antibody, Cytochrome P450 IIA3 antibody, Cytochrome P450(I) antibody, P450C2A antibody, P450PB antibody
Catalogue No.:FNab02155Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, IHC, WB
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
  • CITATIONS
Product Name
CYP2A6 antibody
Catalogue No.
FNab02155
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
cytochrome P450, family 2, subfamily A, polypeptide 6
Alternative Names
Coumarin 7 hydroxylase antibody, CPA6 antibody, CYP2A antibody, CYP2A3 antibody, CYP2A6 antibody, CYPIIA6 antibody, Cytochrome P450 2A6 antibody, Cytochrome P450 IIA3 antibody, Cytochrome P450(I) antibody, P450C2A antibody, P450PB antibody
UniProt ID
P11509
Observed MW
50 kDa
Application
Tested Applications
ELISA, IHC, WB
Recommended dilution
WB: 1:500-1:2000; IHC: 1:50-1:500
Validated Images
HepG2 cells were subjected to SDS PAGE followed by western blot with FNab02155(CYP2A6 antibody) at dilution of 1:1000
Immunohistochemistry of paraffin-embedded human liver tissue slide using FNab02155(CYP2A6 Antibody) at dilution of 1:200
Background
Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Acts as a 1,4-cineole 2-exo-monooxygenase. Possesses low phenacetin O-deethylation activity.
IF: 5.6
Journal:
International Journal of Molecular Sciences
Author:
Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm?tna 12, 31-343 Kraków, Poland
Cited Date:
2023-12-08
Product:
IF: 4.4
Journal:
Pharmacological Reports
Author:
Department of Pharmacokinetics and Drug Metabolism, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm?tna 12, 31-343, Kraków, Poland
Cited Date:
2023-10-27
Product: